Ignoring widespread concern over the safety, efficacy and cost of pentavalent vaccines, India’s central health ministry has, this month, approved inclusion of the prophylactic cocktail in the universal immunisation programme in seven of its provinces. Pentavalent vaccine doses, a cocktail of five antigens in a single shot, confers immunity against five paediatric diseases - diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenza type b (Hib), with the last one considered particularly...
More »SEARCH RESULT
Delhi's irony: Urban Poverty-Srinand Jha
Each time 25 year old Salma takes her one year old son Zubair to the Batla Clinic (a private clinic in Delhi) for a shot of the DPT, the cost of transportation and the vaccine adds up to approximately Rs.500. When it is time for Zubair to take the next immunization dose, Salma may find that the expenses have entirely spiraled out of her reach. New vaccines and expensive brands of baby...
More »A historic move to make drugs affordable-G Ananthakrishnan
India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...
More »Political Challenges to Universal Access to Healthcare by R Srivatsan & Veena Shatrugna
While welcoming the report of the High Level Expert Group on Universal Health Coverage for India for its comprehensive vision and many well-conceived recommendations, this article focuses on the conditions needed for its promise to bear fruit. Towards this, it explores the political dimension, which comprises the forces and interests that come into play to shape and reconfigure administrative policy and its implementation. We are grateful to Anand Zachariah and Susie...
More »How to usher in vaccinnovation in India by MK Bhan
-The Economic Times Vaccines are a true gift of science to humanity. In developing countries, prevention is better than cure. Vaccines have a great track record of safety and efficacy and they are amongst the most cost-effective products, which even the poor have access to due to effective systems of procurement and delivery. India's contribution in the vaccine arena is noteworthy. The primary reason behind the country's vaccine success story is...
More »